A pre-clinical mouse study last year of the drug also offered new insights into a potential mechanism of...
16.00 Mon 30 Mar 2020
MaxCyte: Allogene deal is validation for new CAR-T wave
Shield Therapeutics (STX) detailed a series of achievements in its FY19 business...
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.